Rock Point Advisors, LLC Johnson & Johnson Transaction History

Rock Point Advisors, LLC

$358 Million
Q3 2024

A detailed history of Rock Point Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Rock Point Advisors, LLC holds 6,103 shares of JNJ stock, worth $881,700. This represents 0.28% of its overall portfolio holdings.

Number of Shares

6,103

Previous 6,103 -0.0%

Holding current value

$881,700

Previous $892,000 10.87%

% of portfolio

0.28%

Previous 0.27%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$144.38 - $157.78 $10,106 - $11,044	70 Added 1.16%	6,103 $892,000
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $15,522 - $16,274	100 Added 1.69%	6,033 $954,000
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $23,362 - $26,172	-150 Reduced 2.47%	5,933 $924,000
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $108,045 - $116,277	700 Added 13.0%	6,083 $1.01 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $49,846 - $59,485	-330 Reduced 5.78%	5,383 $834,000
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $98,411 - $109,507	-610 Reduced 9.65%	5,713 $933,000
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $17,828 - $19,717	-106 Reduced 1.65%	6,323 $1.12 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $25,144 - $28,554	-159 Reduced 2.41%	6,429 $1.14 Million
Q4 2021 Feb 09, 2022	BUY	$155.93 - $173.01 $13,877 - $15,397	89 Added 1.37%	6,588 $1.13 Million
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $6,307 - $7,239	-46 Reduced 0.7%	6,499 $1.02 Million
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $47,588 - $52,148	-339 Reduced 4.92%	6,545 $974,000
Q2 2020 Aug 12, 2020	SELL	$128.81 - $155.51 $36,324 - $43,853	-282 Reduced 3.94%	6,884 $968,000
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $74,686 - $103,481	-672 Reduced 8.57%	7,166 $940,000
Q4 2019 Feb 06, 2020	BUY	$127.5 - $146.44 $21,547 - $24,748	169 Added 2.2%	7,838 $1.14 Million
Q3 2019 Nov 08, 2019	BUY	$126.95 - $142.14 $27,040 - $30,275	213 Added 2.86%	7,669 $992,000
Q1 2019 May 08, 2019	SELL	$125.72 - $139.79 $24,892 - $27,678	-198 Reduced 2.59%	7,456 $1.04 Million
Q4 2018 Jan 31, 2019	BUY	$122.84 - $147.84 $12,775 - $15,375	104 Added 1.38%	7,654 $988,000
Q3 2018 Nov 07, 2018	SELL	$121.58 - $142.88 $21,884 - $25,718	-180 Reduced 2.33%	7,550 $1.04 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $42,984 - $47,433	360 Added 4.88%	7,730 $938,000
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $5,004 - $5,925	-40 Reduced 0.54%	7,370 $944,000
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $54,587 - $59,745	416 Added 5.95%	7,410 $1.04 Million
Q3 2017 Nov 03, 2017	BUY	$129.47 - $135.38 $905,513 - $946,847	6,994	6,994 $909,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rock Point Advisors, LLC with notifications on news.

Account

Rock Point Advisors, LLC Johnson & Johnson Transaction History